Lymphocyte transformation test is not helpful for the diagnosis of methotrexate-induced pneumonitis in patients with rheumatoid arthritis

Clinica Chimica Acta

Volumn 407, Issue 1-2, 2009, Pages 25-29

  Hirata, Shintaro ^a   Hattori, Noboru ^a   Kumagai, Kazuhiko ^a   Haruta, Yoshinori ^a   Yokoyama, Akihito ^b   Kohno, Nobuoki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KOCHI UNIVERSITY   (Japan)

Author keywords

Lymphocyte transformation test (LTT); Methotrexate (MTX); MTX induced pneumonitis

Indexed keywords

DNA; METHOTREXATE; THYMIDINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DNA SYNTHESIS; DRUG BLOOD LEVEL; DRUG RESPONSE; DRUG WITHDRAWAL; HUMAN; HUMAN CELL; HYPERSENSITIVITY REACTION; LYMPHOCYTE TRANSFORMATION TEST; MITOGENESIS; PNEUMONIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELL PROLIFERATION; HUMANS; LYMPHOCYTE ACTIVATION; METHOTREXATE; PNEUMONIA; REPRODUCIBILITY OF RESULTS; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

EID: 67651085502     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.06.024     Document Type: Article

References (19)

1. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 46 (2002) 328-346
2. Dawson J.K., Graham D.R., Desmond J., Fewins H.E., and Lynch M.P. Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests. Rheumatology (Oxford) 41 (2002) 262-267
3. Louie S., and Lillington G.A. Low dose methotrexate pneumonitis in rheumatoid arthritis. Thorax 41 (1986) 703-704
4. Cannon G.W., Ward J.R., Clegg D.O., Samuelson Jr. C.O., and Abbott T.M. Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis. Arthritis Rheum 26 (1983) 1269-1274
5. Cooper Jr. J.A., White D.A., and Matthay R.A. Drug-induced pulmonary disease. Part 1: cytotoxic drugs. Am Rev Respir Dis 133 (1986) 321-340
6. Leduc D., De Vuyst P., Lheureux P., Gevenois P.A., Jacobovitz D., and Yernault J.C. Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis. Discrepancies between lung biopsy and bronchoalveolar lavage findings. Chest 104 (1993) 1620-1623
7. Kano Y., Hirahara K., Mitsuyama Y., Takahashi R., and Shiohara T. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 62 (2007) 1439-1444
8. Pichler W.J., and Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59 (2004) 809-820
9. Matsushima H., Takayanagi N., Kawata I., et al. Two fatal cases of methotrexate-induced interstitial pneumonitis (in Japanese). Nihon Kokyuki Gakkai Zasshi 40 (2002) 249-255
10. Matsuno O., Okubo T., Hiroshige S., et al. Drug-induced lymphocyte stimulation test is not useful for the diagnosis of drug-induced pneumonia. Tohoku J Exp Med 212 (2007) 49-53
11. Takei Y., Usui N., Hagino T., et al. Primary central nervous system lymphoma developing methotrexate pneumonitis due to high-dose treatment (in Japanese). Jpn J Chem 51 (2003) 758-761
12. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
13. Imokawa S., Colby T.V., Leslie K.O., and Helmers R.A. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 15 (2000) 373-381
14. Prevoo M.L., van't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., and van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38 (1995) 44-48
15. Nakajima A., Hakoda M., Yamanaka H., Kamatani N., and Kashiwazaki S. Divergent effects of methotrexate on the clonal growth of T and B lymphocytes and synovial adherent cells from patients with rheumatoid arthritis. Ann Rheum Dis 55 (1996) 237-242
16. Olsen N.J., and Murray L.M. Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum 32 (1989) 378-385
17. Johnston C., Russell A.S., and Aaron S. The effect of in vivo and in vitro methotrexate on lymphocyte proliferation as measured by the uptake of tritiated thymidine and tritiated guanosine. Clin Exp Rheumatol 6 (1988) 391-393
18. Dervieux T., Orentas Lein D., Marcelletti J., et al. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis. Clin Chem 49 (2003) 1632-1641
19. Kremer J.M., Alarcon G.S., Weinblatt M.E., et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum 40 (1997) 1829-1837